NCT03576417: A Trial Evaluating the Addition of Nivolumab to Cisplatin-RT for Treatment of Cancers of the Head and Neck
- State
- Under way
- Phase
- Phase 3
- People
- 680 taking part
- Started
- 10 Oct 2018
- Primary completion
- Aug 2027
- Arms
- RT+ cisplatin + nivolumab
- Results
- None posted
- 3 Jul 2018: Trial registered
- 10 Oct 2018: Trial started